These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 19485754)
1. Challenges and progress in the development of a serogroup B meningococcal vaccine. Lewis S; Sadarangani M; Hoe JC; Pollard AJ Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754 [TBL] [Abstract][Full Text] [Related]
2. Meningococcal serogroup B infections: a search for a broadly protective vaccine. Vermont CL; van den Dobbelsteen GP Expert Rev Vaccines; 2003 Oct; 2(5):673-81. PubMed ID: 14711328 [TBL] [Abstract][Full Text] [Related]
6. Recent developments in vaccines to prevent meningococcal serogroup B infections. Vermont CL; van den Dobbelsteen GP; de Groot R Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468 [TBL] [Abstract][Full Text] [Related]
7. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand. Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Sanders H; Feavers IM Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800 [TBL] [Abstract][Full Text] [Related]
9. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613 [TBL] [Abstract][Full Text] [Related]
11. Phase II meningococcal B vesicle vaccine trial in New Zealand infants. Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease. Norheim G; Arne Høiby E; Caugant DA; Namork E; Tangen T; Fritzsønn E; Rosenqvist E Vaccine; 2004 Jun; 22(17-18):2171-80. PubMed ID: 15149774 [TBL] [Abstract][Full Text] [Related]
13. Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness. Poolman JT; Richmond P Expert Rev Vaccines; 2015; 14(9):1277-87. PubMed ID: 26204792 [TBL] [Abstract][Full Text] [Related]
14. A review of vaccine research and development: meningococcal disease. Girard MP; Preziosi MP; Aguado MT; Kieny MP Vaccine; 2006 May; 24(22):4692-700. PubMed ID: 16621189 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate. Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338 [TBL] [Abstract][Full Text] [Related]
16. Review of meningococcal group B vaccines. Granoff DM Clin Infect Dis; 2010 Mar; 50 Suppl 2(S2):S54-65. PubMed ID: 20144017 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Snape MD; Dawson T; Oster P; Evans A; John TM; Ohene-Kena B; Findlow J; Yu LM; Borrow R; Ypma E; Toneatto D; Pollard AJ Pediatr Infect Dis J; 2010 Nov; 29(11):e71-9. PubMed ID: 20844462 [TBL] [Abstract][Full Text] [Related]
18. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine. Bai X; Borrow R Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270 [TBL] [Abstract][Full Text] [Related]
19. [Vaccinal strategies in response to new epidemiological challenges in 2010. Reasonable hope for a "B" meningococcal vaccine]. Nicolas P Med Trop (Mars); 2010 Aug; 70(4):325-32. PubMed ID: 22368926 [TBL] [Abstract][Full Text] [Related]
20. Advances towards the prevention of meningococcal B disease: a multidimensional story. Roderick M; Finn A J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]